342 related articles for article (PubMed ID: 30324323)
1. Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve.
Di Mario C; Petricca L; Gigante MR; Barini A; Barini A; Varriano V; Paglionico A; Cattani P; Ferraccioli G; Tolusso B; Gremese E
Endocrine; 2019 Feb; 63(2):369-375. PubMed ID: 30324323
[TBL] [Abstract][Full Text] [Related]
2. Assessment of ovarian reserve by serum anti-Müllerian hormone in patients with systemic lupus erythematosus: a meta-analysis.
Luo W; Mao P; Zhang L; Chen X; Yang Z
Ann Palliat Med; 2020 Mar; 9(2):207-215. PubMed ID: 32156138
[TBL] [Abstract][Full Text] [Related]
3. Brief Report: The Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen Does Not Impact the Ovarian Reserve, as Measured by Serum Levels of Anti-Müllerian Hormone.
Tamirou F; Husson SN; Gruson D; Debiève F; Lauwerys BR; Houssiau FA
Arthritis Rheumatol; 2017 Jun; 69(6):1267-1271. PubMed ID: 28235250
[TBL] [Abstract][Full Text] [Related]
4. Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus.
Mok CC; Chan PT; To CH
Arthritis Rheum; 2013 Jan; 65(1):206-10. PubMed ID: 23044647
[TBL] [Abstract][Full Text] [Related]
5. Anti-Müllerian hormone in reproductive age women with systemic lupus erythematosus.
Velarde-Ochoa Mdel C; Esquivel-Valerio JA; Vega-Morales D; Skinner-Taylor CM; Galarza-Delgado DÁ; Garza-Elizondo MA
Reumatol Clin; 2015; 11(2):78-82. PubMed ID: 24815955
[TBL] [Abstract][Full Text] [Related]
6. Assessment of anti-Müllerian hormone levels in premenopausal patients with systemic lupus erythematosus.
Gasparin AA; Souza L; Siebert M; Xavier RM; Chakr RM; Palominos PE; Brenol JC; Monticielo OA
Lupus; 2016 Mar; 25(3):227-32. PubMed ID: 26223296
[TBL] [Abstract][Full Text] [Related]
7. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate?
de Araujo DB; Yamakami LY; Aikawa NE; Bonfá E; Viana VS; Pasoto SG; Pereira RM; Serafin PC; Borba EF; Silva CA
Scand J Rheumatol; 2014; 43(6):503-11. PubMed ID: 24881927
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of ovarian reserve with anti-Müllerian hormone in female patients with systemic lupus erythematosus].
Chen D; Yuan S; Zhan Z; Zhan Y; Yang X; Liang L
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):977-80. PubMed ID: 24851682
[TBL] [Abstract][Full Text] [Related]
9. Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus.
Martins NFE; Seixas MI; Pereira JP; Costa MM; Fonseca JE
Clin Rheumatol; 2017 Dec; 36(12):2853-2854. PubMed ID: 28828533
[TBL] [Abstract][Full Text] [Related]
10. Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone.
Lawrenz B; Henes J; Henes M; Neunhoeffer E; Schmalzing M; Fehm T; Kïtter I
Lupus; 2011 Oct; 20(11):1193-7. PubMed ID: 21768179
[TBL] [Abstract][Full Text] [Related]
11. Regular menstrual cycles do not rule out ovarian damage in adult women with systemic lupus erythematosus.
Malheiro OB; Rezende CP; Rocha AL; Del Puerto HL; Ferreira GA; Reis FM
Gynecol Endocrinol; 2014 Oct; 30(10):701-4. PubMed ID: 24898133
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients.
Marder W; McCune WJ; Wang L; Wing JJ; Fisseha S; McConnell DS; Christman GM; Somers EC
Gynecol Endocrinol; 2012 Aug; 28(8):624-7. PubMed ID: 22296584
[TBL] [Abstract][Full Text] [Related]
13. [Anti-Müllerian hormone levels as a predictor of ovarian reserve in systemic lupus erythematosus patients: a review].
Gasparin AA; Chakr RM; Brenol CV; Palominos PE; Xavier RM; Souza L; Brenol JC; Monticielo OA
Rev Bras Reumatol; 2015; 55(4):363-7. PubMed ID: 25583001
[TBL] [Abstract][Full Text] [Related]
14. Preliminary study on the changes of ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age.
Gao H; Ma J; Wang X; Lv T; Liu J; Ren Y; Li Y; Zhang Y
Lupus; 2018 Mar; 27(3):445-453. PubMed ID: 28820360
[TBL] [Abstract][Full Text] [Related]
15. Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy.
Aikawa NE; Sallum AM; Pereira RM; Suzuki L; Viana VS; Bonfá E; Silva CA
Clin Exp Rheumatol; 2012; 30(3):445-9. PubMed ID: 22703605
[TBL] [Abstract][Full Text] [Related]
16. Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide.
Morel N; Bachelot A; Chakhtoura Z; Ghillani-Dalbin P; Amoura Z; Galicier L; Aumaitre O; Piette JC; Pourrat J; Boutin D; Sacre K; Kahn JE; Duhaut P; Farge D; Francès C; Guettrot-Imbert G; Harlé JR; Lambotte O; Le Guern V; Sène D; Trad S; Vidal E; Sarrot-Reynauld F; Gompel A; Tanguy ML; Touraine P; Lacorte JM; Costedoat-Chalumeau N;
J Clin Endocrinol Metab; 2013 Sep; 98(9):3785-92. PubMed ID: 23833039
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone in African-American women with systemic lupus erythematosus.
Angley M; Spencer JB; Lim SS; Howards PP
Lupus Sci Med; 2020 Nov; 7(1):. PubMed ID: 33132225
[TBL] [Abstract][Full Text] [Related]
18. Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy.
Ma W; Zhan Z; Liang X; Chen J; Huang X; Liao C
J Womens Health (Larchmt); 2013 Dec; 22(12):1023-7. PubMed ID: 24283710
[TBL] [Abstract][Full Text] [Related]
19. Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behçet's disease and spondyloarthritis on anti-Müllerian hormone levels.
Henes M; Froeschlin J; Taran FA; Brucker S; Rall KK; Xenitidis T; Igney-Oertel A; Lawrenz B; Henes JC
Rheumatology (Oxford); 2015 Sep; 54(9):1709-12. PubMed ID: 25957439
[TBL] [Abstract][Full Text] [Related]
20. Ovarian function and disease activity in patients with systemic lupus erythematosus.
Shabanova SS; Ananieva LP; Alekberova ZS; Guzov II
Clin Exp Rheumatol; 2008; 26(3):436-41. PubMed ID: 18578965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]